Brief: Orexo Partners With Lyfebulb
May 18 (Reuters) - Orexo AB ORX.ST :
* WILL PARTNER WITH LYFEBULB TO WORK WITH SUBSTANCE ABUSE
PATIENTS
TO IDENTIFY UNMET NEEDS MADE MORE ACUTE BY PANDEMIC, AND TO
INNOVATE NEW SOLUTIONS
Source text for Eikon: ID:nWkr3YPdnm
Further company coverage: ORX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Orexo AB
See all newsBrief: Orexo Announces Positive Outcome From An In-Vivo Study Of Ox390
Brief: Orexo Announces Positive Outcome From An In-Vivo Study Of Ox390
Brief: Orexo Announces Positive Pre-Clinical Data For Nasal Atipamezole Using Amorphox Technology
Brief: Orexo AB Reports Q1 2026 Net Revenue Of Sek 5.0 Million
Sweden's Orexo Q1 revenue drops, net loss widens